SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-021897
Filing Date
2021-04-16
Accepted
2021-04-16 16:15:20
Documents
2
Period of Report
2021-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea139602-8k_silo.htm 8-K 17242
2 AMENDMENT NO. 1 TO PATENT LICENSE AGREEMENT, DATED APRIL 12, 2021, BY AND AMONG ea139602ex10-1_silo.htm EX-10.1 12364
  Complete submission text file 0001213900-21-021897.txt   31117
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 21831677
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl